VNDA Stock-Based Compensation
Vanda Pharmaceuticals Inc · Stock-Based Compensation
VNDA Stock-Based Compensation
Latest reported$11.63Mperiod ending
VNDA TTM Stock-Based Comp ($0.00 → $11.63M)
TTM stock-based compensation
High-resolution chart · PNG
VNDA stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 11,630,000 | |
| 9,066,000 | |
| 9,474,000 | |
| 10,052,000 | |
| 10,939,000 | |
| 11,819,000 | |
| 12,432,000 | |
| 12,842,000 | |
| 13,010,000 | |
| 13,273,000 | |
| 14,040,000 | |
| 14,550,000 | |
| 15,271,000 | |
| 15,852,000 | |
| 16,279,000 | |
| 16,270,000 | |
| 16,333,000 | |
| 16,243,000 | |
| 15,374,000 | |
| 14,812,000 | |
| 13,996,000 | |
| 13,325,000 | |
| 13,360,000 | |
| 13,816,000 | |
| 14,088,000 | |
| 14,120,000 | |
| 13,458,000 | |
| 12,712,000 | |
| 12,177,000 | |
| 11,797,000 | |
| 11,666,000 | |
| 11,526,000 | |
| 11,425,000 | |
| 11,360,000 | |
| 10,465,000 | |
| 9,786,000 | |
| 9,115,000 | |
| 8,533,000 | |
| 8,543,000 | |
| 8,327,000 | |
| 8,288,000 | |
| 8,282,000 | |
| 7,961,000 | |
| 7,705,000 | |
| 7,055,000 | |
| 6,430,000 | |
| 5,878,000 | |
| 5,530,000 | |
| 5,658,000 | |
| 5,045,000 | |
| 4,604,000 | |
| 4,244,000 | |
| 3,281,000 | |
| 3,644,000 | |
| 4,094,000 | |
| 4,489,000 | |
| 5,167,000 | |
| 5,299,000 | |
| 5,501,000 | |
| 5,518,471 | |
| 5,151,192 | |
| 5,465,178 | |
| 4,982,000 | |
| 6,168,030 | |
| 8,710,669 | |
| 10,042,402 | |
| 11,230,227 | |
| 22,096,515 | |
| 18,667,155 | |
| 15,696,436 | |
| 13,387,789 | |
| 19,622,814 | |
| 19,622,814 | |
| 19,622,814 | |
| 4,127,594,814 | |
| 10,239,799,000 | |
| 10,239,799,000 | |
| 10,239,799,000 | |
| 7,652,144,000 | |
| 1,520,317,000 | |
| 1,520,317,000 | |
| 1,520,317,000 | |
| 0 |